[go: up one dir, main page]

ES2181702T3 - MELATONIN DERIVATIVES FOR USE IN THE TREATMENT OF ILLNESS IS SLEEP. - Google Patents

MELATONIN DERIVATIVES FOR USE IN THE TREATMENT OF ILLNESS IS SLEEP.

Info

Publication number
ES2181702T3
ES2181702T3 ES94308466T ES94308466T ES2181702T3 ES 2181702 T3 ES2181702 T3 ES 2181702T3 ES 94308466 T ES94308466 T ES 94308466T ES 94308466 T ES94308466 T ES 94308466T ES 2181702 T3 ES2181702 T3 ES 2181702T3
Authority
ES
Spain
Prior art keywords
illness
sleep
treatment
melatonin derivatives
melatonin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94308466T
Other languages
Spanish (es)
Inventor
Michael Edward Flaugh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of ES2181702T3 publication Critical patent/ES2181702T3/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention provides a method of treating sleep disorders using various melatonin analogs. The invention further provides pharmaceutical formulations suitable for use in such method.
ES94308466T 1993-11-18 1994-11-16 MELATONIN DERIVATIVES FOR USE IN THE TREATMENT OF ILLNESS IS SLEEP. Expired - Lifetime ES2181702T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/154,332 US5654325A (en) 1993-11-18 1993-11-18 Melatonin derivatives for use in treating sleep disorders

Publications (1)

Publication Number Publication Date
ES2181702T3 true ES2181702T3 (en) 2003-03-01

Family

ID=22550932

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94308466T Expired - Lifetime ES2181702T3 (en) 1993-11-18 1994-11-16 MELATONIN DERIVATIVES FOR USE IN THE TREATMENT OF ILLNESS IS SLEEP.

Country Status (21)

Country Link
US (1) US5654325A (en)
EP (1) EP0655243B1 (en)
JP (1) JPH07196493A (en)
KR (1) KR950013508A (en)
CN (1) CN1092958C (en)
AT (1) ATE222491T1 (en)
AU (1) AU684313B2 (en)
CA (1) CA2135709C (en)
CZ (1) CZ288835B6 (en)
DE (1) DE69431199T2 (en)
DK (1) DK0655243T3 (en)
ES (1) ES2181702T3 (en)
HU (1) HUT72069A (en)
IL (1) IL111580A (en)
NO (1) NO309964B1 (en)
NZ (1) NZ264892A (en)
PH (1) PH31098A (en)
PT (1) PT655243E (en)
RU (1) RU2146140C1 (en)
SG (1) SG50505A1 (en)
ZA (1) ZA948927B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0748627A3 (en) * 1995-06-14 1997-05-21 Lilly Co Eli Melatonin agonists for use in the treatment of benign prostatic hyperplasia
CA2357114C (en) * 2001-03-22 2010-06-29 Pooger Properties Ltd. Use of melatonin in the manufacture of a medicament for treating attention deficit hyperactive disorder
WO2002079153A1 (en) * 2001-03-28 2002-10-10 Biocatalytics, Inc. Method for producing tryptamine derivatives
IL144900A (en) * 2001-08-14 2013-12-31 Neurim Pharma 1991 Melatonin and medicaments comprising it for use in treating primary insomnia and in the manufacture of such medicaments
EP1545511B1 (en) * 2002-09-26 2007-05-09 Pooger Properties Limited Combined use of methylphenidate and melatonin for treating attention-deficit hyperactive disorder
US20070128310A1 (en) 2003-12-19 2007-06-07 Meni-One Co., Ltd. Astaxanthin-containing pet foods
WO2005062851A2 (en) * 2003-12-22 2005-07-14 Pappolla Miguel A Indole-3-propionamide and derivatives thereof
EP1715742A4 (en) * 2004-02-20 2009-06-17 Lifescape Biosciences Inc Compositions and methods for sleep regulation
DE102005008312A1 (en) * 2005-02-17 2006-08-24 Birds Pharma Gmbh Berolina Innovative Research & Development Services Use of deuterated N- [2- (5-methoxy-1H-indol-3-yl) ethyl] acatamide and their pharmaceutically acceptable salts and medicaments containing these compounds
US20060223877A1 (en) * 2005-03-31 2006-10-05 Zemlan Frank P Methods of treatment utilizing certain melatonin derivatives
TWI402261B (en) * 2006-06-19 2013-07-21 Takeda Pharmaceutical Tricyclic compound and pharmaceutical use thereof
ES2324849A1 (en) * 2007-10-25 2009-08-17 Ferrer Internacional, S.A. Indane compounds

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087444A (en) * 1976-09-08 1978-05-02 Eli Lilly And Company Amides as ovulation inhibitors
IT1148618B (en) * 1982-10-11 1986-12-03 Polifarma Spa ENZYMATIC PROCEDURE FOR THE PRODUCTION OF 3-INDOLPIRUVIC ACID AND PHARMACEUTICAL USE OF THIS
EP0126630B1 (en) * 1983-05-18 1987-09-16 Monash University The use of melatonin for the manufacture of a medicament
US4600723A (en) * 1983-05-18 1986-07-15 Monash University Method for minimizing disturbances in circadian rhythms of bodily performance and function
US4614807A (en) * 1984-10-04 1986-09-30 Eli Lilly And Company 6,7-dihalomelatonins
US4687763A (en) * 1985-02-25 1987-08-18 Massachusetts Institute Of Technology Composition and method for increasing levels or release of brain serotonin
US4997845A (en) * 1987-02-02 1991-03-05 Eli Lilly And Company β-alkylmelatonins as ovulation inhibitors
US5093352A (en) * 1988-11-14 1992-03-03 Whitby Research, Inc. Antidepressant agents
WO1989001472A1 (en) * 1987-08-17 1989-02-23 Nelson Research & Development Co. Melatonin analogues
DE4002840A1 (en) * 1990-01-29 1991-08-01 Gerhard Dr Stechmesser Treating stress-induced regulation disorders - by exposing patient to additional stress and then administering drug e.g. substance P or butiroxan
JPH0418034A (en) * 1990-05-11 1992-01-22 Kanegafuchi Chem Ind Co Ltd Eye drop composition
US5242941A (en) * 1990-12-04 1993-09-07 State Of Oregon Methods of treating circadian rhythm disorders
IT1251544B (en) * 1991-05-13 1995-05-17 Gabriele Biella PHARMACEUTICAL COMPOSITIONS ACTIVE IN THE THERAPY OF SLEEP DISORDERS INCLUDING MELATONIN OR A DERIVATIVE IN ASSOCIATION WITH A BENZODIAZEPINE DERIVATIVE
ZA928011B (en) * 1991-10-18 1993-06-23 Alza Corp Transdermal administration of melatonin.
US5196435A (en) * 1991-11-21 1993-03-23 Eli Lilly And Company Melatonin derivatives and combinations with antiestrogen compounds for treating mammalian breast carcinoma
IT1254995B (en) * 1992-06-24 1995-10-11 DRUG CONTAINING MELATONIN AND / OR AGONISTS, WITH PARTICULARLY EFFECTIVE ADMINISTRATION IN PATHOLOGIES THAT INTERFER WITH CIRCANDIAN RHYTHMS
IT1255199B (en) * 1992-07-01 1995-10-20 Franco Fraschini SYNTHESIZED DRUG ANALOG OF MELATONIN PARTICULARLY EFFECTIVE IN THE PATHOLOGIES THAT INTERFER WITH CIRCADIAN RHYTHMS
US5449683A (en) * 1992-10-01 1995-09-12 Massachussetts Institute Of Technology Methods of inducing sleep using melatonin

Also Published As

Publication number Publication date
ATE222491T1 (en) 2002-09-15
RU2146140C1 (en) 2000-03-10
NO944339D0 (en) 1994-11-14
CA2135709A1 (en) 1995-05-19
SG50505A1 (en) 1998-07-20
RU94040886A (en) 1996-09-20
EP0655243A2 (en) 1995-05-31
CZ288835B6 (en) 2001-09-12
CZ276594A3 (en) 1995-07-12
CA2135709C (en) 2007-01-02
HUT72069A (en) 1996-03-28
ZA948927B (en) 1996-05-10
NZ264892A (en) 1997-07-27
EP0655243A3 (en) 1995-10-11
DK0655243T3 (en) 2002-10-07
CN1107701A (en) 1995-09-06
US5654325A (en) 1997-08-05
DE69431199T2 (en) 2003-03-27
JPH07196493A (en) 1995-08-01
HU9403300D0 (en) 1995-01-30
NO309964B1 (en) 2001-04-30
AU684313B2 (en) 1997-12-11
DE69431199D1 (en) 2002-09-26
IL111580A0 (en) 1995-01-24
NO944339L (en) 1995-05-19
KR950013508A (en) 1995-06-15
AU7777794A (en) 1995-05-25
PH31098A (en) 1998-02-05
CN1092958C (en) 2002-10-23
IL111580A (en) 1999-10-28
EP0655243B1 (en) 2002-08-21
PT655243E (en) 2002-11-29

Similar Documents

Publication Publication Date Title
DK0513702T3 (en) Melatonin derivatives for use in the treatment of sleep disorders and for pre-anesthetic medication
ES2166111T3 (en) USE OF TIAGABINE FOR THE TREATMENT OF SLEEP DISORDERS.
ES2181702T3 (en) MELATONIN DERIVATIVES FOR USE IN THE TREATMENT OF ILLNESS IS SLEEP.
ATE137965T1 (en) USE OF TOMOXETINE TO TREAT LOWER URINARY TRACT DISORDERS
ES2170176T3 (en) USE OF ANTAGONISTS OF SEROTONINE AND DOPAMINE RECEPTORS FOR THE TREATMENT OF MENTAL DISEASES RESULTING FROM CEREBROVASCULAR DISEASES.
PT656209E (en) MELATONIN DERIVATIVES FOR USE IN THE TREATMENT OF DESSINCRONIZATION PERTURBACES
MX9704034A (en) DERIVATIVES AND COMPOSITIONS OF SUBSTITUTED 2-ARYLCARBONYLOXYMETHYL-1,2,5-TIADIAZOLIDIN-3-ONA 1,1-DIOXIDE AND METHOD OF USE.
ES1034986Y (en) APPARATUS FOR THE TREATMENT OF THE HUMAN BODY.
ATE201993T1 (en) USE OF OLNZAPINE IN THE PRODUCTION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF CEREBRAL FOCAL ISCHEMIA
MX9203208A (en) PHARMACEUTICAL COMPOSITION AND METHOD FOR THE TREATMENT OF DIGESTIVE DISORDERS.
PT1304107E (en) USE OF OXAZOLIDININ DERIVATIVES FOR THE TREATMENT OF PSORIASIS
MX9307679A (en) DERIVATIVES OF FURANONE USEFUL IN THERAPY.
ES1006595Y (en) APPARATUS FOR THE CONTROL OF PSYCHO-PHYSIOLOGICAL TENSIONS OF THE HUMAN BODY.
BR8904799A (en) PHOTOTHERAPY APPARATUS FOR THE TREATMENT OF ICTERICIA OF THE NEWBORN
ES1014237Y (en) APPARATUS FOR THE CONTROL OF PSYCHO-PHYSIOLOGICAL TENSIONS OF THE HUMAN BODY.
NO950842L (en) Diarylpiperazinoacetamide compounds as antimuscarinic agents
ITMI911058A0 (en) USE OF PYRIDOXINE PYRROLIDONCARBOXYATE FOR THE TREATMENT OF DEPRESSIVE AFFECTIVE DISORDERS